Global Non-Insulin Therapies for Diabetes Market Revenue Projected Around USD 105,461 Million By 2027 by Market Research Store

According to the report, the global demand for non-insulin therapies for diabetes market was valued at approximately USD 61,090 million in 2018 and is expected to reach a value of around USD 105,461 million by 2027, at a CAGR of around 6.3% between 2019 and 2027.

A large number of patients affected due to type 2 diabetes can cope with it by making a few lifestyle changes as well as alterations in diet intake. They can integrate the changes with non-insulin tablets. In type 1 diabetes, doctors recommend a combination medical treatment that comprises of non-insulin medicines. The non-insulin diabetes treatment comprises of oral and injectable drugs. Moreover, oral drugs that are recommended for effectively handling diabetes include Sodium-glucose cotransporter-2 (SGLT2) inhibitors, Sodium-glucose cotransporter-2 (SGLT2) inhibitors, metformin, and Alpha-glucosidase inhibitors (AGIs). The highly recommended injectable non-insulin medicines include Glucagon-like peptide-1 (GLP-1) agonists as well as Amylin analogs.

Download Free PDF Sample Of This Report : https://www.marketresearchstore.com/report/non-insulin-therapies-for-diabetes-market-by-product-699917#RequestSample

Swiftly surging diabetic population pool to drive the market growth

The prominent rise in the diabetic population base is anticipated to steer the expansion of the non-insulin therapies for diabetes industry over the forecast timeline. Apart from this, the rise in the cases of type 2 diabetes in children will boost the production of non-insulin diabetes medicines, thereby steering the growth of the non-insulin therapies for diabetes market. In addition to this, the ratio of patients affected from type 2 diabetes is huge in most of the countries and this will further steer the market surge over the forecast timeline. Apparently, technological breakthroughs will complement the progression of the industry from the period of 2019 to 2027.

Full Report with Toc : https://www.marketresearchstore.com/report/non-insulin-therapies-for-diabetes-market-by-product-699917

Furthermore, development of new non-insulin diabetes drugs like thiazolidinediones, glucagon-like peptide 1 analogs, dipeptidyl peptidase-4 inhibitors, and glinides for treating diabetes will propel the scope of the business during the period from 2019 to 2027. Nonetheless, the strict legislations pertaining to production of new drugs for treating diabetes can decimate the market expansion over the forecast timeline. In addition to this, the long process of approving of the drugs may further obstruct the market progression over the forecast timeline.

Oral segment to dominate the product landscape over the forecast timespan

The segment is projected to accrue the revenue of nearly USD 94,600 by the end of 2027. The growth of the segment is credited to the massive demand for oral products as well as oral delivery & oral administration of the drugs.

Hospital Pharmacy segment to contribute majorly towards the overall market revenue
Hospital pharmacy segment is projected to accrue a revenue of nearly USD 52,800 million by 2027. Huge sale of non-insulin drugs from hospital pharmacies has soared the growth of the segment.

North America to dominate the regional market growth

North American market is projected to accumulate revenue worth nearly USD 35,090 million by the end of the forecast timeframe. The growth of the market in North America is attributed to the massive application of non-insulin therapies for treating diabetes in countries like the U.S.

The key players in this market are 3SBio Group, Alkem Labs., Eli Lilly and Company, Emisphere Technologies, Eurofarma Laboratórios S.A., GEROPHARM, GlaxoSmithKline plc., Intarcia Therapeutics, Inc., Jiangsu Hengrui Medicine, Luye Pharma Group, Merck Sharp & Dohme Corp. (subsidiary of Merck & Co., Inc), Novo Nordisk, Pfizer Inc., Servier, Sumitomo Dainippon Pharma Co., Ltd., Ildong, and Syneos Health.

3422 SW 15 Street,Suit #8138,
Deerfield Beach,Florida 33442, USA
Tel: +1-386-310-3803GMT
Tel: +49-322 210 92714

Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.

This release was published on openPR.